['lizbeth]

I am so happy that Genentech and others continued the research beyond Herceptin.

These numbers are a bit shocking. I suppose because everyone is lumped in together.
I am truly looking forward to seeing long range data for the Herceptin/Perjeta combination.

The Disease Free Survival and Overall Survival numbers for the current generation of Her2 breast cancer patients will be even better. What a difference a decade makes!